137 related articles for article (PubMed ID: 17593333)
1. Mechanisms of HER2-induced endothelial cell retraction.
Carter WB; Niu G; Ward MD; Small G; Hahn JE; Muffly BJ
Ann Surg Oncol; 2007 Oct; 14(10):2971-8. PubMed ID: 17593333
[TBL] [Abstract][Full Text] [Related]
2. Alteration of interendothelial adherens junctions following tumor cell-endothelial cell interaction in vitro.
Lewalle JM; Bajou K; Desreux J; Mareel M; Dejana E; Noël A; Foidart JM
Exp Cell Res; 1997 Dec; 237(2):347-56. PubMed ID: 9434630
[TBL] [Abstract][Full Text] [Related]
3. HER2 regulatory control of angiopoietin-2 in breast cancer.
Carter WB; Ward MD
Surgery; 2000 Aug; 128(2):153-8. PubMed ID: 10922985
[TBL] [Abstract][Full Text] [Related]
4. Geldanamycin destabilizes HER2 tyrosine kinase and suppresses Wnt/beta-catenin signaling in HER2 overexpressing human breast cancer cells.
Wang K; Ma Q; Ren Y; He J; Zhang Y; Zhang Y; Chen W
Oncol Rep; 2007 Jan; 17(1):89-96. PubMed ID: 17143483
[TBL] [Abstract][Full Text] [Related]
5. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy.
Schäfer R; Abraham D; Paulus P; Blumer R; Grimm M; Wojta J; Aharinejad S
Circulation; 2003 Sep; 108(13):1585-91. PubMed ID: 12963640
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling.
Labelle M; Schnittler HJ; Aust DE; Friedrich K; Baretton G; Vestweber D; Breier G
Cancer Res; 2008 Mar; 68(5):1388-97. PubMed ID: 18316602
[TBL] [Abstract][Full Text] [Related]
7. Cadherins and catenins in breast cancer.
Cowin P; Rowlands TM; Hatsell SJ
Curr Opin Cell Biol; 2005 Oct; 17(5):499-508. PubMed ID: 16107313
[TBL] [Abstract][Full Text] [Related]
8. IQGAP1 mediates VE-cadherin-based cell-cell contacts and VEGF signaling at adherence junctions linked to angiogenesis.
Yamaoka-Tojo M; Tojo T; Kim HW; Hilenski L; Patrushev NA; Zhang L; Fukai T; Ushio-Fukai M
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):1991-7. PubMed ID: 16763158
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting E-cadherin/catenin complex formation.
Yuan Z; Wong S; Borrelli A; Chung MA
Biochem Biophys Res Commun; 2007 Oct; 362(3):740-6. PubMed ID: 17764657
[TBL] [Abstract][Full Text] [Related]
10. Role of cadherins in the transendothelial migration of melanoma cells in culture.
Sandig M; Voura EB; Kalnins VI; Siu CH
Cell Motil Cytoskeleton; 1997; 38(4):351-64. PubMed ID: 9415377
[TBL] [Abstract][Full Text] [Related]
11. HER2 signaling--induced microvessel dismantling.
Carter WB
Surgery; 2001 Aug; 130(2):382-7. PubMed ID: 11490375
[TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 opens endothelial cell junctions by targeting catenins.
Kronstein R; Seebach J; Grossklaus S; Minten C; Engelhardt B; Drab M; Liebner S; Arsenijevic Y; Taha AA; Afanasieva T; Schnittler HJ
Cardiovasc Res; 2012 Jan; 93(1):130-40. PubMed ID: 21960684
[TBL] [Abstract][Full Text] [Related]
13. Cdc42 regulates adherens junction stability and endothelial permeability by inducing alpha-catenin interaction with the vascular endothelial cadherin complex.
Broman MT; Kouklis P; Gao X; Ramchandran R; Neamu RF; Minshall RD; Malik AB
Circ Res; 2006 Jan; 98(1):73-80. PubMed ID: 16322481
[TBL] [Abstract][Full Text] [Related]
14. Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer.
Vazquez-Martin A; Colomer R; Menendez JA
Eur J Cancer; 2007 May; 43(7):1117-24. PubMed ID: 17379503
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids increase VE-cadherin expression and cause cytoskeletal rearrangements in murine brain endothelial cEND cells.
Blecharz KG; Drenckhahn D; Förster CY
J Cereb Blood Flow Metab; 2008 Jun; 28(6):1139-49. PubMed ID: 18231113
[TBL] [Abstract][Full Text] [Related]
16. Expression of early placenta insulin-like growth factor in breast cancer cells provides an autocrine loop that predominantly enhances invasiveness and motility.
Brandt B; Kemming D; Packeisen J; Simon R; Helms M; Feldmann U; Matuschek A; Kersting C; Hinrichs B; Bidart JM; Bellet D; Bartkowiak K; Dankbar N; Dittmar T; Sauter G; Boecker W; Buerger H
Endocr Relat Cancer; 2005 Dec; 12(4):823-37. PubMed ID: 16322324
[TBL] [Abstract][Full Text] [Related]
17. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site.
Wallez Y; Cand F; Cruzalegui F; Wernstedt C; Souchelnytskyi S; Vilgrain I; Huber P
Oncogene; 2007 Feb; 26(7):1067-77. PubMed ID: 16909109
[TBL] [Abstract][Full Text] [Related]
18. Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity: evidence for tumor necrosis factor α-induced VE-cadherin cleavage.
Sidibé A; Mannic T; Arboleas M; Subileau M; Gulino-Debrac D; Bouillet L; Jan M; Vandhuick T; Le Loët X; Vittecoq O; Vilgrain I
Arthritis Rheum; 2012 Jan; 64(1):77-87. PubMed ID: 21905018
[TBL] [Abstract][Full Text] [Related]
19. Early response of endothelial cells to flow is mediated by VE-cadherin.
Rabodzey A; Yao Y; Luscinskas FW; Shaw SK; Dewey CF
Cell Commun Adhes; 2007; 14(5):195-209. PubMed ID: 18163230
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1beta reduces transcellular monocyte diapedesis and compromises endothelial adherens junction integrity.
Ferreira AM; McNeil CJ; Stallaert KM; Rogers KA; Sandig M
Microcirculation; 2005; 12(7):563-79. PubMed ID: 16207629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
